Pentazocine and naloxone - Pentazocine hydrochloride and naloxone hydrochloride
Navigation: NDC > Supplier starting with: W > WATSON LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 0591-0395 |
| Proprietary Name: | Pentazocine and naloxone |
| Suffix: | |
| Non-Proprietary Name: | Pentazocine hydrochloride and naloxone hydrochloride |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 21-01-1997 |
| Category Name: | ANDA |
| Application Number: | ANDA074736 |
| Labeler: | WATSON LABORATORIES, INC. |
| Substance Name: | NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE |
| Active Numerator Strength: | .5; 50 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| DEA Schedule: | CIV |